Esophageal Neoplasms: all 1,631 studies
Page 3 of 17. Open to participants first (469), then studies with results posted, then the rest; newest registration first within each.
- A PhaseⅠ/Ⅱ Study of Simmitinib or Irinotecan Liposomes Combined With DP303c in Gastric Adenocarcinoma or Gastroesophageal Junction AdenocarcinomaNot yet recruitingNCT06577376Phase 1/2
- Trilaciclib Combined With Concurrent Chemoradiotherapy and Immunotherapy in the Treatment of Esophageal CancerRecruitingNCT06569459Phase 2
- Registry for Esophageal and Gastroesophageal Junction CancerRecruitingNCT06558786
- HER2 Status in Esophagogastric Adenocarcinoma and Its Associations With Patient's Clinicopathological OutcomesRecruitingNCT06550063
- TIL Therapy Combined With Pembrolizumab for Advanced or Metastatic Refractory Stomach and Esophageal CancerRecruitingNCT06532799Phase 1/2
- A Study of Barrett's Esophagus Patients to Investigate Quality of Life and Fear of Cancer, and Optimize a Risk Model Based on Biomarkers and New Technologies to Better Predict the Development of CancerRecruitingNCT06523374Not applicable
- China Early Esophageal Cancer CohortRecruitingNCT06515964
- Goal-directed Enteral Nutritional Perioperative ManagementRecruitingNCT06510543Not applicable
- A Study of BL-M17D1 in Patients With Locally Advanced or Metastatic HER2 Positive/Lower Expression Gastrointestinal Cancer and Other Solid TumorsRecruitingNCT06500052Phase 1
- MRD-Guided Consolidation Therapy Following Definitive Radiotherapy in Esophageal CancerRecruitingNCT06498752Phase 2
- Definitive Radiotherapy for Cervical and Upper Thoracic Esophageal Cancer (ChC&UES): A Multi-center Real World StudyRecruitingNCT06481449
- Novel Bipolar Radiofrequency Ablation Knife in Esophageal LesionsRecruitingNCT06476678
- Predicting Early Tumor Recurrence in Patients With Esophageal Squamous Cell CarcinomaRecruitingNCT06476067
- A Trial of SHR-A2102 With Adebrelimab With or Without Other Antitumor Therapy in Advanced or Metastatic Esophageal CancerRecruitingNCT06474468Phase 1/2
- Substudy 06C: A Study of Investigational Agents With Pembrolizumab (MK-3475) and Chemotherapy in Participants With First-Line Locally Advanced Unresectable/Metastatic Gastroesophageal Adenocarcinoma (MK-3475-06C/KEYMAKER-U06)RecruitingNCT06469944Phase 1/2
- Feasibility and Added Value of the TRACMOTION Device for ESDNot yet recruitingNCT06468800Not applicable
- A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid TumorsRecruitingNCT06465069Phase 1
- Induction Immunochemotherapy Followed by Concurrent Chemoradiotherapy in Patients With ESCC.RecruitingNCT06452602Phase 2
- Cancer Loyalty Card Study 2 (CLOCS-2)RecruitingNCT06447064
- Substudy 06D: Combination Therapies in Second Line (2L) Gastroesophageal Adenocarcinoma (MK-3475-06D/Keymaker-U06)RecruitingNCT06445972Phase 1/2
- Understanding the Variation of Modern Endoscopic Ultrasound Use in Patients With Oesophageal Cancer (VALUE)RecruitingNCT06440174
- Hematoporphyrin Photodynamic Therapy for Esophageal CancerEnrolling by invitationNCT06437288Phase 4
- Neoadjuvant Comprehensive Treatment for Unresectable Esophageal CancerRecruitingNCT06430658Phase 2
- Exercise Prehabilitation for Locoregional Esophageal CancerRecruitingNCT06430346Not applicable
- Nimotuzumab Concurrent With Chemoradiotherapy for Esophageal Cancer PatientsRecruitingNCT06429839Phase 2
- Induction Chemoimmunotherapy Combined With Chemoradiotherapy in Esophageal CancerRecruitingNCT06421376Phase 2
- Clinical Study on the Effect of Removal of Porphyromonas Gingivalis on Prognosis of Esophageal Cancer After Radical SurgeryNot yet recruitingNCT06418945Phase 3
- Early Detection of Esophageal Squamous Cancer With the Capsule Sponge DeviceNot yet recruitingNCT06418516Not applicable
- A Study of Paclitaxel Combined With Apatinib and Adebrelimab in Gastric/Gastroesophageal Junction AdenocarcinomaRecruitingNCT06415669Phase 2
- 18F-AraG PET/CT as a Non-Invasive Imaging Biomarker for Chemoradiation Treatment Response in Esophageal CancerRecruitingNCT06414902Phase 1
- HER-2 B Cell Peptide VaccineRecruitingNCT06414733Phase 1
- Modulated Mid-frequency Whole-body Electromyostimulation and Nutritional Therapy in Gastrointestinal Cancer PatientsNot yet recruitingNCT06414122Not applicable
- Multimodal Endoscopic Image Fusion for Assessing Infiltration in Superficial Esophageal Squamous Cell CarcinomaNot yet recruitingNCT06412419
- Nimotuzumab Concurrent With Chemoradiotherapy for Patients With Unresectable Esophageal Squamous Cell CarcinomaRecruitingNCT06410651Phase 2
- Predicting Esophageal Cancer Borders Using PET-ImagingRecruitingNCT06408116Phase 2
- Study of The Second-line Treatment of Advanced Gastric / Gastroesophageal Junction Adenocarcinoma With Cadonilimab and Fruquintinib Combined With Paclitaxel-albuminRecruitingNCT06406426Phase 2
- Safety and Efficacy of Neoadjuvant Immunochemotherapy in Elderly Patients With Resectable Esophageal CancerRecruitingNCT06403878Phase 2
- A Phase II Clinical Study of Epigallocatechin-3-gallate in Patients With Esophageal Squamous CancerRecruitingNCT06398405Phase 2
- The Study on the Mechanism of Radiotherapy-elicited Immune ResponseRecruitingNCT06393140
- Deep-sea Fish Oil for Prevention of Acute Radiation-induced EsophagitisRecruitingNCT06392971Phase 2
- Neoadjuvant PD-1 Blockade for Elderly Esophageal Squamous Cell Carcinoma (BLESS)RecruitingNCT06385730Phase 2
- Multicenter Cohort Study of ESD and Chemo-radiotherapy for High-risk Early-stage Esophageal CancerRecruitingNCT06385717
- A Phase I/II Trial of UCB4594 in Participants With Advanced CancerRecruitingNCT06380816Phase 1/2
- Prediction Models for Complications After CRT in Esophageal CancerRecruitingNCT06366828
- Development and Initial Application of a Combined Exercise and Psychological Intervention Program for Patients After EsophagectomyNot yet recruitingNCT06366685Not applicable
- Evaluate the Efficacy of Adding Intraluminal Brachytherapy After CCRT for Local-regional Thoracic Esophageal Cancer.RecruitingNCT06365866Not applicable
- Esophageal Self-expandable Metal Stent for Malignant Strictures: a Safety and Efficacy StudyRecruitingNCT06364553Not applicable
- Conebeam CT-based Online Adaptive Radio-Therapy for Esophageal Cancer (ARTEC)RecruitingNCT06361043
- Prehab for Lung and Esophageal CancerRecruitingNCT06354959Not applicable
- Serplulimab Combined With Concurrent Chemoradiotherapy for Locally Advanced Treatment Esophageal Cancer in Old AgeRecruitingNCT06354218Phase 2
- Claudin 18.2-Targeted Chimeric Antigen Receptor T-cells for Gastric/Gastroesophageal Junction AdenocarcinomaRecruitingNCT06353152Phase 1
- Immune Checkpoint Inhibitor Response in Solid Tumors Using a Live Tumor Diagnostic PlatformRecruitingNCT06349642
- Prediction of Anastomotic Complications and Recurrent Laryngeal Nerve Injury Based on Postoperative Early Endoscopic EvaluationRecruitingNCT06348381
- Molecular Analysis for Gastro-Esophageal Cancer: Multicenter Discrete Choice ExperimentRecruitingNCT06346080Not applicable
- Molecular Assessment for Gastro-Esophageal CancerRecruitingNCT06346054Not applicable
- Volume Outcome Relationships and EffectsRecruitingNCT06343597
- A Study of AK104/Placebo Plus AK109/Placebo And Paclitaxel in Gastric or Gastroesophageal Junction AdenocarcinomaRecruitingNCT06341335Phase 3
- An Organ Preservation Strategies After Chemoradiotherapy Combined With Immunotherapy for Esophageal Cancer (PALACE3).RecruitingNCT06339060Phase 3
- Study of IBI343 in Subjects With Advanced Gastric/Gastroesophageal Junction AdenocarcinomaNot yet recruitingNCT06321913Phase 2
- Pembrolizumab Combined With Preoperative Chemotherapy (Albumin Paclitaxel+Carboplatin) Neoadjuvant Therapy for Resectable Locally Advanced (Stage II/III) Esophageal Squamous Cell CarcinomaRecruitingNCT06304350Phase 2
- A Prospective Study on Esophagogastrostomy by an Innovative Surgical TechniqueRecruitingNCT06300879Not applicable
- 64Cu-LNTH-1363S in Patients With Sarcoma or Gastrointestinal Tract CancerRecruitingNCT06298916Phase 1/2
- Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid TumorsRecruitingNCT06293898Phase 1
- A Trial of Palliative Chemotherapy, Radiation and Immune Treatment for Oesophageal Cancer: PALEO StudyRecruitingNCT06290505Phase 2
- Exosome-based Liquid Biopsies for Upper Gastrointestinal Cancers DiagnosisRecruitingNCT06278064
- POP-UP: a Single-arm, Two-cohort Study: an 8-week Trimodal Pre-habilitation Program for Patients With Pancreatic Ductal Adenocarcinoma and OesogastricRecruitingNCT06275737Not applicable
- Comparison of In-Home Versus In-Clinic Administration of Subcutaneous Nivolumab Through Cancer CARE (Connected Access and Remote Expertise) Beyond Walls (CCBW) ProgramRecruitingNCT06265285Phase 2
- EQUITY GI: A Prospective Study to Enhance Quality, Inclusivity, and Trial Participation in Black Patients With Gastrointestinal Cancer.RecruitingNCT06263088Not applicable
- Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid TumorsRecruitingNCT06239194Phase 1/2
- A Multi Tumor, Open Phase I Clinical Study on the Progression of First-line Anti-tumor Therapy Using Cardonizumab Combined With Pulsed Low-dose Rate External Irradiation (PLDR)RecruitingNCT06232083Phase 1
- Thalidomide Prevention or Treatment of Camrelizumab-induced Reactive Cutaneous Capillary Endothelial Proliferation (RCCEP)RecruitingNCT06231680Phase 2
- DV Combined With Cadonilimab in Subjects With HER2-expressing Gastric Cancer and Gastroesophageal Junction Adenocarcinoma After Progression on First-line TherapyRecruitingNCT06221748Phase 2/3
- Clinical Efficacy and Safety of Paclitaxel Polymeric Micelles for Injection in the Treatment of Patients With Taxans-resistant Pancreatic Adenocarcinoma, Cholangiocarcinoma, Lung Cancer, Gastric Cancer, Esophageal Carcinoma, or Breast CancerRecruitingNCT06199895Phase 2
- Functional Imaging to Identify Radiosensitive Esophageal Cancer - a Biomarker Validation StudyRecruitingNCT06189898
- Serologic Response to Pneumococcal Vaccination Among Esophageal Cancer Patients With High Grade Lymphopenia After ChemoradiationRecruitingNCT06181656
- Immunotherapy in Combination With Chemoradiotherapy in Unresectable Locally Advanced Esophageal CancerRecruitingNCT06173986Phase 1/2
- A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid TumorsRecruitingNCT06172478Phase 2
- Volatile Organic Compounds as Breath Biomarkers in Squamous Oesophageal NeoplasmsRecruitingNCT06169163
- Camrelizumab Combined With Chemotherapy and Radiotherapy Perioperative Treatment of Esophageal Gastric Junction AdenocarcinomaRecruitingNCT06163729Phase 2
- Total Neoadjuvant Therapy for Lymph Node-positive Adenocarcinoma of the OESophagus and Oesophagogastric JunctionRecruitingNCT06161818Phase 2
- A Clinical Study of Non-curative Resection Plus Radiotherapy After Endoscopic ESD for Superficial Esophageal Squamous Cell CarcinomaEnrolling by invitationNCT06160557
- A Study of PD-1 Inhibitors Combined With Fruquintinib and Chemotherapy in First-line Treatment of HER2-negative Advanced G/GEJ CancerRecruitingNCT06158919Not applicable
- Comparison of Long-term Survival and Quality of Life After Minimally Invasive Esophagectomy Versus Open EsophagectomyNot yet recruitingNCT06147180
- The Correlation Between Microbiome of Esophageal Cancer Patients and Post Esophagectomy Anastomotic LeaksRecruitingNCT06136845
- Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid TumorsRecruitingNCT06128551Phase 1/2
- Clinical Study of CEA Targeting Chimeric Antigen Receptor T Lymphocytes（CAR-T） for CEA Positive Advanced Malignant Solid TumorsRecruitingNCT06126406Phase 1
- SHR-A1811 for Subjects With Her2-positive Gastric Cancer and Gastroesophageal Junction Adenocarcinoma After Progression on or After First-line Anti-HER2 Therapy-containing RegimenRecruitingNCT06123494Phase 3
- A Study of Pembrolizumab With Trastuzumab and Chemotherapy in People With Esophagogastric CancerRecruitingNCT06123338Phase 2
- Radiotherapy + Chemoimmunotherapy Followed by Surgery in Patients With Limited Metastatic Gastric or GEJ CancerRecruitingNCT06121700Phase 2
- HS-20093 in Patients with Advanced Esophageal Carcinoma and Other Advanced Solid TumorsRecruitingNCT06112704Phase 2
- Rhomboid Intercostal and Subserratum Plane Block for Minimally Invasive EsophagectomyRecruitingNCT06092944Not applicable
- XELOX Combined With Fruquintinib and Sintilimab Regimen Conversion Therapy for Gastric Cancer/Gastroesophageal Junction Adenocarcinoma Only With Liver and/or Retroperitoneal Lymph Node Metastasis, a Prospective Single-arm, Multicenter StudyRecruitingNCT06091423Phase 2
- PD-1 Inhibitor Plus Chemotherapy With or Without Radiotherapy in Patients With Metastatic Esophageal CancerRecruitingNCT06086457Phase 3
- Radiotherapy in Patients With Metastatic Esophageal Cancer Responding to PD-1 Inhibitor Plus ChemotherapyRecruitingNCT06084897Phase 2
- The Efficacy and Safety of the COMBO Endoscopy Oropharyngeal Airway in Gastrointestinal Endoscopy ProcedureRecruitingNCT06081647Not applicable
- Comparison of 0.4% Hyaluronic Acid Solution Versus Hydroxyethylamide Solution in Submucosal Endoscopic ResectionsRecruitingNCT06077981Not applicable
- Comparative Study Between (FC-SEMS) and (PC-SEMS) in the Palliation of Dysphagia Due to Malignant Neoplasm of Esophagus.RecruitingNCT06070376Not applicable
- Amiodarone for the Prevention of Atrial Fibrillation After Minimally Invasive Esophagectomy in Patients With Esophageal CancerRecruitingNCT06067438Phase 2
- Sacituzumab Govitecan in Combination With Capecitabine for Advanced Gastrointestinal Cancers After Progression on Standard TherapyRecruitingNCT06065371Phase 1
- Tislelizumab Plus Concurrent Chemoradiation in Older With ESCCRecruitingNCT06061146Phase 2